STOCK TITAN

Charlton Aria Acquisition Corporation (CHAR) DEF 14A Filings

CHAR NASDAQ

Here are the DEF 14A proxy statements from Charlton Aria Acquisition Corporation (CHAR) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow CHAR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CHAR filings page.

Rhea-AI Summary

Charlton Aria Acquisition Corp. asks shareholders to approve up to 12 one-month extensions of its business-combination deadline, from October 25, 2026 through October 25, 2027. The Sponsor, its affiliates or designees would deposit funds for each extension. Shareholders also vote on a related trust-agreement amendment and, if needed, adjournment; the business combination is not on this meeting’s ballot.

Charlton signed an agreement with KQC Quantum, Inc. on October 6, 2026. The transaction’s Equity Value is $80 million, with consideration expected to equal one Parent Class A share per Charlton share. Closing requires at least $30 million in available cash, unless the parties agree otherwise, plus shareholder approval, an effective registration statement and Nasdaq listing approval. Pre-closing Parent common-stock holders may receive up to 1,500,000 earnout shares over five years, with thresholds of $12.50, $15.00 and $20.00.

If the extension is not approved and no business combination is completed by October 25, 2026, Charlton would cease operations and liquidate. Its trust held approximately $93.5 million as of September 25, 2026, and the estimated redemption price was approximately $11.00 per share.